STOCK TITAN

AdaptHealth (AHCO) Stock News, Jun-Dec 2022

AHCO NASDAQ

AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.

Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.

Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:00 PM PT. The presentation will be available via a live webcast on the company's investor website. AdaptHealth specializes in patient-centered healthcare-at-home solutions, providing a range of medical equipment and supplies to help manage chronic conditions. The company serves approximately 3.9 million patients annually across the United States through a network of 750 locations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the BofA Securities Home Care Conference on December 5 at 2:00 pm ET. CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will represent the company. A live webcast and replay will be available on AdaptHealth's investors page, with attendees encouraged to register early. AdaptHealth is a leading provider of healthcare-at-home solutions, serving approximately 3.9 million patients annually across 750 locations in 47 states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.25%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) reported record net revenue of $756.5 million for Q3 2022, up 15.8% from $653.3 million in Q3 2021. However, net income dropped to $16.1 million ($0.11 per share) from $58.1 million ($0.20 per share) year-over-year. Adjusted EBITDA increased slightly to $160.2 million, while cash flow from operations rose significantly to $107.0 million. The company updated its fiscal year 2022 guidance, projecting net revenue between $2.950 billion and $3.010 billion, reflecting strong demand in the healthcare-at-home market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.14%
Tags
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will announce its third quarter 2022 financial results before the market opens on November 8, 2022. Management will hold a teleconference at 8:30 a.m. ET to discuss the results and ongoing business activities with analysts and investors. AdaptHealth is a leader in providing healthcare-at-home solutions, serving around 3.9 million patients annually through over 750 locations in 47 states, focusing on home medical equipment, medical supplies, and related services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
conferences earnings
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced new long-term financial goals during its 2022 Capital Markets Day. CEO Steve Griggs highlighted the company's progress in establishing a scalable foundation for profitable growth and shareholder value. The company aims to lead the shift to connected in-home healthcare, emphasizing its commitment to cost-effective patient care. AdaptHealth serves approx. 3.9 million patients annually, leveraging operational excellence and strategic acquisitions. The firm is focused on enhancing its chronic disease management programs and expanding its connected care offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.22%
Tags
none
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will host its first Capital Markets Day on September 16, 2022, at 9:00 a.m. ET. The event aims to present the Company’s business model, market position, and long-term strategies for growth and profitability. CEO Steve Griggs emphasizes the importance of connecting with investors and analysts. The event will be webcast live, with additional materials available on AdaptHealth’s website. This initiative reflects AdaptHealth's commitment to providing healthcare-at-home solutions and reaching approximately 3.9 million patients annually across the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.53%
Tags
conferences
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) reported second-quarter financial results for 2022, highlighting a net revenue of $727.6 million, a 17.9% increase from $617.0 million in 2021. Adjusted EBITDA rose 1.8% to $150.0 million, with an EBITDA margin improvement to 20.6%. However, net income dropped to $14.0 million from $79.1 million year-over-year. Non-acquired net revenue slightly decreased by 0.3%. The company maintained its 2022 guidance, projecting net revenue between $2.840 billion and $3.040 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.53%
Tags
-
News
Rhea-AI Summary

AdaptHealth Corp. (NASD: AHCO) will be added to the S&P SmallCap 600 index, effective August 4, 2022. This change comes as Cummins Inc. (NYSE: CMI) is acquiring Meritor Inc. (NYSE: MTOR), which is being removed from the index. The transition reflects a strategic reshuffle in the S&P indices as AdaptHealth enhances its presence in the health care sector. The acquisition of Meritor by Cummins is expected to complete soon, pending closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.3%
Tags
none
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q2 2022 financial results before market open on August 9, 2022. A teleconference hosted by management is scheduled for 8:30 a.m. ET to discuss the results and future business activities. Participants can join by calling (877) 407-6176 for domestic or (201) 689-8451 for international calls. A replay will be available for six months on the company's website under 'Investor Relations'. AdaptHealth offers patient-centered healthcare-at-home solutions, serving 3.9 million patients yearly across 50 states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
conferences earnings
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has announced that Josh Parnes, President, and Jason Clemens, CFO, will participate in a fireside chat at the Jefferies Healthcare Conference on June 8 at 10:00 am ET. A live webcast will be available on AdaptHealth's website for those interested in attending.

AdaptHealth is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the United States.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
conferences

FAQ

What is the current stock price of AdaptHealth (AHCO)?

AdaptHealth (AHCO) last closed at $6.02.

What is the market cap of AdaptHealth (AHCO)?

The market cap of AdaptHealth (AHCO) is approximately $803.1M.